腾讯入股帆礼生物技术公司

Core Viewpoint - Recently, Fanli Biotechnology (Ningbo) Co., Ltd. underwent a business change, adding Guangxi Tencent Venture Capital Co., Ltd. as a shareholder and increasing its registered capital to 6.8189 million yuan [1] Company Summary - Fanli Biotechnology was established in 2023 and is represented by legal representative Fan Pengcheng [1] - The company's business scope includes medical research and experimental development, excluding human stem cell, gene diagnosis, and treatment technology development and application [1]